» Articles » PMID: 32359562

AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis

Overview
Specialty Gastroenterology
Date 2020 May 4
PMID 32359562
Citations 97
Authors
Affiliations
Soon will be listed here.
Citing Articles

An Esophageal Luminal Diameter of 16 mm Predicts Dysphagia Resolution in Eosinophilic Esophagitis.

Beveridge C, Hermanns C, Thanawala S, Yang Q, Qin Y, Thota P Dig Dis Sci. 2025; .

PMID: 40024960 DOI: 10.1007/s10620-025-08874-7.


Dupilumab in children with eosinophilic esophagitis: a retrospective multicenter study.

Hasosah M, Sukkar G, AlSahafi A, Zaidan A, Ghous N, Alshahrani A BMC Pediatr. 2025; 25(1):100.

PMID: 39910505 PMC: 11796247. DOI: 10.1186/s12887-024-05313-w.


Eosinophilic esophagitis in the "atopic march": dupilumab as an "umbrella" strategy for multiple coexisting atopic diseases.

Lutzu N, Favale A, Demurtas M, Del Giacco S, Onali S, Fantini M Front Med (Lausanne). 2025; 11:1513417.

PMID: 39906352 PMC: 11790572. DOI: 10.3389/fmed.2024.1513417.


Practice patterns for eosinophilic esophagitis vary widely among Canadian gastroenterologists: a nationwide survey.

Fetz A, Hemy A, Kim H, Moosavi S J Can Assoc Gastroenterol. 2025; 8(1):13-20.

PMID: 39906276 PMC: 11788507. DOI: 10.1093/jcag/gwae033.


Potassium-Competitive Acid Blockers and Proton Pump Inhibitors: The Dynamic Duo of Acid Blockers.

Ketchem C, Lynch K Gastroenterol Hepatol (N Y). 2025; 20(12):733-738.

PMID: 39886002 PMC: 11776008.


References
1.
Hirano I, Collins M, Assouline-Dayan Y, Evans L, Gupta S, Schoepfer A . RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis. Gastroenterology. 2018; 156(3):592-603.e10. DOI: 10.1053/j.gastro.2018.10.051. View

2.
Reed C, Wolf W, Cotton C, Rusin S, Perjar I, Hollyfield J . Optimal Histologic Cutpoints for Treatment Response in Patients With Eosinophilic Esophagitis: Analysis of Data From a Prospective Cohort Study. Clin Gastroenterol Hepatol. 2017; 16(2):226-233.e2. PMC: 6582220. DOI: 10.1016/j.cgh.2017.09.046. View

3.
Sultan S, Falck-Ytter Y, Inadomi J . The AGA institute process for developing clinical practice guidelines part one: grading the evidence. Clin Gastroenterol Hepatol. 2013; 11(4):329-32. DOI: 10.1016/j.cgh.2013.02.001. View

4.
Furuta G, Liacouras C, Collins M, Gupta S, Justinich C, Putnam P . Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007; 133(4):1342-63. DOI: 10.1053/j.gastro.2007.08.017. View

5.
Liacouras C, Furuta G, Hirano I, Atkins D, Attwood S, Bonis P . Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011; 128(1):3-20.e6. DOI: 10.1016/j.jaci.2011.02.040. View